Viaken Secures $13 Million in Second Round Funding | GenomeWeb

NEW YORK, June 25 – Bioinformatics provider Viaken Systems of Gaithersburg, Md., said Monday it has closed $13 million in second-round equity funding. 

Sterling Venture Partners was the lead investor, along with new participating investors MacAndrews & Forbes, Allianz, Schoffstall Ventures, and E-media, and repeat investors Core Capital Partners and Mid-Atlantic Venture Funds. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.